Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.19.6: pyroglutamyl-peptidase II

This is an abbreviated version!
For detailed information about pyroglutamyl-peptidase II, go to the full flat file.

Word Map on EC 3.4.19.6

Reaction

release of the N-terminal pyroglutamyl group from pGlu-/-His-Xaa tripeptides and pGlu-/-His-Xaa-Gly tetrapeptides =

Synonyms

aminopeptidase, thyrotropin-releasing factor pyroglutamate, PAP type II, PPII, pyroglutamate aminopeptidase II, pyroglutamyl aminopeptidase II, pyroglutamyl peptidase II, pyrrolidone carboxypeptidase type II, thyroliberin-hydrolyzing pyroglutamate aminopeptidase, thyroliberinase, thyrotropin-releasing hormone-degrading peptidase, thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase, TRH aminopeptidase, TRH-DE, TRH-degrading ectoenzyme, TRH-degrading enzyme, TRH-specific aminopeptidase

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.19 Omega peptidases
                3.4.19.6 pyroglutamyl-peptidase II

Inhibitors

Inhibitors on EC 3.4.19.6 - pyroglutamyl-peptidase II

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
1,3-benzodioxol-5-amine
-
-
1,7-phenanthroline
-
10 mM, 67% inhibition
2-Aminobenzyl alcohol
-
-
2-hydroxyaniline
-
-
2-Phenylethylamine
-
-
3,4-dimethoxyaniline
-
-
3,5-dimethoxyaniline
-
-
3-(trifluoromethoxy)aniline
-
-
3-phenyl-1-propylamine
-
-
4,7-phenanthroline
-
10 mM, 56% inhibition
4-(2-aminoethyl)-benzenesulfonylfluoride
-
66% inhibition at 1 mM, 97% inhibition at 10 mM
4-(trifluoromethyl)aniline
-
-
4-amino-N-methylphthalamide
-
-
4-phenylbutylamine
-
-
5,6,7,8-tetrahydro-1-naphthylamine
-
-
5-amino-2-chloropyridine
-
-
5-amino-2-methoxyphenol
-
-
5-aminoindan
-
-
5-chloro-2-methoxyaniline
-
-
5-oxoproline
-
product inhibition at high concentration
6-amino-1,3-dihydroisobenzofuran-1-one
-
-
6-amino-2-mercaptobenzothiazole
-
-
6-amino-3,4-benzocoumarin
-
-
7-amino-4-methylcoumarin
-
-
8-hydroxyquinoline
-
10 mM, 68% inhibition
benzyl alcohol
-
-
benzylamine
-
-
CDTA
-
10 mM, 10% inhibition
Chelating agents
-
-
CuSO4
DTT
-
-
Glp-Asn-Pro-D-Tyr-D-Trp-7-amido-4-methyl-coumarin
-
-
Glp-Asn-Pro-D-Tyr-D-Trp-D-Trp-7-amido-4-methyl-coumarin
-
-
Glp-Asn-Pro-D-Tyr-D-TrpNH2
-
potent inhibitor of TRH-DE. Competetive, fully reversible and not time dependent inhibition
Glp-Asn-Pro-Tyr-Trp-7-amido-4-methyl-coumarin
-
-
Glp-Asn-Pro-Tyr-Trp-Trp-7-amido-4-methyl-coumarin
-
-
Glp-Asn-Pro-Tyr-TrpNH2
-
-
Glp-PSI[P(O)(OH)CH2]-His-Pro-NH2
Hermodice carunculata inhibitor
-
Hermodice carunculata peptidase inhibitor
-
HcPI
-
His-Pro-NH2
-
product inhibition at high concentration
L-pyroglutamyl-Asn-Pro-NH2
-
inhibition is fully reversible
Luliberin
Luteinizing hormone releasing hormone
-
-
m-anisidine
-
-
m-phenethidine
-
-
metal chelators
-
methyl alcohol
-
-
methylamine
-
-
MgSO4
-
0.1 mM
NEM
-
10 mM, 22% inhibition
neurotensin
-
-
Ni2+
-
-
o-anisidine
-
-
p-anisidine
-
-
p-Glu-Asn-Pro-7-amido-4-methylcoumarin
-
PCMB
-
-
Peptides containing N-terminal pyroglutamyl residues
-
-
-
puromycin
-
1 mM, 17% inhibition
pyroglutamyl-7-amido-4-methylcoumarin
-
-
pyroglutamyl-Asn(N-benzyl)-ProNH2
-
-
pyroglutamyl-Asn(N-hydroxyl)-ProNH2
-
-
pyroglutamyl-Asn(N-methyl)-ProNH2
-
-
pyroglutamyl-Asn(N-phenyl)-ProNH2
-
-
pyroglutamyl-Asn-Pro-7-amido-4-methyl coumarin
-
-
pyroglutamyl-Asn-Pro-7-amido-4-methylcoumarin
-
-
pyroglutamyl-Asn-Pro-NH2
-
-
pyroglutamyl-Asn-Pro-Ser-TyrNH2
-
-
pyroglutamyl-Asn-Pro-Trp-7-amido-4-methylcoumarin
-
-
pyroglutamyl-Asn-Pro-Trp-Trp-7-amido-4-methylcoumarin
-
-
pyroglutamyl-Asn-Pro-Trp-TyrNH2
-
-
pyroglutamyl-Asn-Pro-TrpNH2
-
-
pyroglutamyl-Asn-Pro-Tyr-Trp-7-amido-4-methylcoumarin
-
-
pyroglutamyl-Asn-Pro-Tyr-Trp-Trp-7-amido-4-methylcoumarin
-
-
pyroglutamyl-Asn-Pro-Tyr-Trp-TrpNH2
-
-
pyroglutamyl-Asn-Pro-Tyr-TrpNH2
-
-
pyroglutamyl-Asn-Pro-TyrNH2
-
-
pyroglutamyl-Asn-ProNH2
-
-
pyroglutamyl-Gln-Pro-NH2
-
-
pyroglutamyl-Gly-Pro-NH2
-
inhibition is fully reversible
pyroglutamyl-His
-
-
Pyroglutamyl-His-Gly
-
-
pyroglutamyl-His-Gly-NH2
-
-
pyroglutamyl-His-Pro
-
-
pyroglutamyl-His-Pro-7-amido-4-methylcoumarin
-
-
pyroglutamyl-His-Pro-Gly
-
-
pyroglutamyl-His-Pro-Gly-NH2
-
-
pyroglutamyl-His-Pro-NH2
-
-
pyroglutamyl-His-Trp-Ser-Tyr-Gly
-
-
pyroglutamyl-His-Trp-Ser-Tyr-Gly-Leu
-
-
pyroglutamyl-His-Trp-Ser-Tyr-Gly-Leu-Arg
-
-
pyroglutamyl-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly
-
-
pyroglutamyl-homoprolyl-Pro-NH2
-
-
pyroglutamyl-L-alpha-phenylglycyl-Pro-NH2
-
-
pyroglutamyl-Phe-Pro-NH2
-
-
pyroglutamyl-Trp-Pro-NH2
-
-
Thyroliberin analogues
-
LLD-thyroliberin, pyroglutamyl-His-Pro-NHCH3, pyroglutamyl-His-Pro-Gly-NHCH3, pyroglutamyl-Phe-Pro-NH2
-
ZnSO4
additional information
-